Publication
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS
Emily Saintas, Liam Abrahams, Gulshan T. Ahmad, Anu-Oluwa M. Ajakaiye, Abdulaziz S. H. A. M. AlHumaidi, Candice Ashmore-Harris, Iain Clark, Usha K. Dura, Carine N. Fixmer, Chinedu Ike-Morris, Mireia Mato Prado, Danielle Mccullough, Shishir Mishra, Katia M. U. Schöler, Husne Timur, Maxwell D. C. Williamson, Markella Alatsatianos, Basma Bahsoun, Edith Blackburn, Catherine E. Hogwood, Pamela E. Lithgow, Michelle Rowe, Lyto Yiangou, Florian Rothweiler, Jindrich Cinatl, Richard Zehner, Anthony J. Baines, Michelle D. Garrett, Campbell W. Gourlay, Darren K. Griffin, William J. Gullick, Emma Hargreaves, Mark J. Howard, Daniel R. Lloyd, Jeremy S. Rossman, C. Mark Smales, Anastasios D. Tsaousis, Tobias von der Haar, Mark N. Wass, Martin Michaelis
PLoS ONE, February 2017, PLOS
DOI: 10.1371/journal.pone.0172140